Table 2.
Summarizes the meta-analysis results and Egger’s test of comorbidities.
| Comorbidity | Number of articles | Number of CP | Event | Heterogeneity | (95% CI) | Prevalence(%) | Publication bias (Egger’s test) | |||
|---|---|---|---|---|---|---|---|---|---|---|
| I2(%) | p value | |||||||||
| t | P value | |||||||||
| Total Comorbidities | 16 | 6,617 | 5,370 | 98.36 | <0.001 | 73.8 | 85.7 | 79.7 | −5.15 | <0.001 |
| Epilepsy | 56 | 29,020 | 5,833 | 76.59 | <0.001 | 15.4 | 20.4 | 17.9 | −3.28 | 0.002 |
| Intellectual disability | 48 | 430,933 | 298,976 | 99.11 | <0.001 | 51.8 | 64.3 | 58.0 | −2.30 | 0.026 |
| Speech disorders | 32 | 21,426 | 7,687 | 97.14 | <0.001 | 41.6 | 54.4 | 48.0 | 1.54 | 0.135 |
| Hearing disorders | 41 | 429,032 | 30,740 | 94.75 | <0.001 | 13.0 | 21.4 | 17.2 | 3.90 | <0.001 |
| Vision disorders | 35 | 419,150 | 22,371 | 97.13 | <0.001 | 16.3 | 29.8 | 23.1 | 4.66 | <0.001 |